ROLE OF18F-FLUORODEOXY GLUCOSE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH CARDIAC SARCOIDOSIS ON LONG-TERM CORTICOSTEROID TREATMENT

ROLE OF18F-FLUORODEOXY GLUCOSE POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH CARDIAC SARCOIDOSIS ON LONG-TERM CORTICOSTEROID TREATMENT

There were no significant differences in New York Heart Association (NYHA) function class, brain natriuretic peptide (BNP), echocardiographic variables, and high-sensitive troponin T between group A and B. Conclusions To reduce or stop corticosteroids, 18F-FDG PET provides useful information for CS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E1260
Hauptverfasser: Yazaki, Yoshikazu, Toshimasa, Seki, Yukiko, Hayashi, Kasai, Hiroki, Hongo, Minoru, Ikeda, Uichi
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Medical research
Sarcoidosis
Tomography
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There were no significant differences in New York Heart Association (NYHA) function class, brain natriuretic peptide (BNP), echocardiographic variables, and high-sensitive troponin T between group A and B. Conclusions To reduce or stop corticosteroids, 18F-FDG PET provides useful information for CS patients on long-term corticosteroid treatment.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)61260-7